Regeneron Pharmaceuticals, Inc. 13D and 13G filings for Intellia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:06 pm Purchase |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
REGENERON PHARMACEUTICALS INC. REGN |
3,702,995 4.980% |
925,218 (+33.31%) |
Filing |